2026 NPPES data Hematology & Oncology Physician NPI 1568588184 MD
Verify on CMS →

CHAMATH DE SILVA, MD

Hematology & Oncology Physician in LAFAYETTE, Colorado. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
795
Medicare Part D claims · 160 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
80%
generic claims · 20% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

CHAMATH DE SILVA, MD filed 795 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in LAFAYETTE, Colorado, prescribing 80% generic.

795
Part D claims, 2023
80%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CHAMATH DE SILVA, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

795 Top 29% higher than 71% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

CHAMATH DE SILVA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about CHAMATH DE SILVA, MD?

Quality data not reported

NPI registry status

Active

Issued 03/22/2007

NPI 1568588184

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

795 6% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Colorado

How Hematology & Oncology Physician compares to other specialties among Colorado providers

Colorado providers

Hematology & Oncology Physician share within Colorado

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Colorado

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CHAMATH DE SILVA, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 280 EXEMPLA CIR, LAFAYETTE, CO, 80026, with a listed phone of (303) 338-3800. NPI 1568588184 was issued on 03/22/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DE SILVA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 795 prescription claims written by this provider, covering 160 Medicare beneficiaries and totaling roughly $2.5 million in drug spend, split 20% brand-name and 80% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

280 EXEMPLA CIR
LAFAYETTE, CO 80026

Provider Details

NPI 1568588184
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 03/22/2007

Hospital and facility affiliations

Facilities where CHAMATH DE SILVA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

COLORADO PERMANENTE MEDICAL GROUP PC
LAFAYETTE, CO
NORTH PLATTE NEBRASKA HOSPITAL CORPORATION
NORTH PLATTE, NE

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Typical

CHAMATH DE SILVA, MD — brand share 20.0%
Specialty average (est.)

20% brand-name claims vs 80% generic, on 795 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

795
Total Claims
$2.5M
Total Drug Cost
160
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,052
Total Day Supply
28,567
Brand vs Generic
20% brand / 80% generic
Brand Drug Cost
$1.6M
Generic Drug Cost
$912K
Antibiotic Claims
22

Patient Demographics

Average Patient Age
75.6 years
Avg HCC Risk Score
2.06
Gender Split
53% female / 47% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What CHAMATH DE SILVA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisone
96
Abiraterone Acetate
85
Anastrozole
75
Lenalidomide
75
Dexamethasone
44
Hydroxyurea
37
Xtandi
Enzalutamide
37
Ondansetron Odt
Ondansetron
28
Xarelto
Rivaroxaban
28
Acyclovir
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How CHAMATH DE SILVA, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

CHAMATH DE SILVA, MD's 795 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Colorado

Other clinicians with the same primary specialty enrolled in Colorado, drawn from the same CMS NPPES roster as DE SILVA.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is CHAMATH DE SILVA, MD's specialty?
CHAMATH DE SILVA, MD specializes in Hematology & Oncology Physician and practices in LAFAYETTE, Colorado. Credentials: MD.
How much does CHAMATH DE SILVA, MD prescribe under Medicare Part D?
In 2023, CHAMATH DE SILVA, MD wrote 795 Medicare Part D claims totaling $2.5M in drug costs for 160 beneficiaries.
Where is CHAMATH DE SILVA, MD located?
CHAMATH DE SILVA, MD is located at 280 EXEMPLA CIR, LAFAYETTE, CO, 80026. Phone: (303) 338-3800.
What is CHAMATH DE SILVA, MD's NPI number?
CHAMATH DE SILVA, MD's National Provider Identifier (NPI) is 1568588184, issued on 03/22/2007.
Does CHAMATH DE SILVA, MD prescribe more brand-name or generic drugs?
CHAMATH DE SILVA, MD's prescribing is 20% brand-name and 80% generic drugs by claim count, with $1.6M in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does CHAMATH DE SILVA, MD prescribe most often?
Based on 2023 Medicare Part D data, CHAMATH DE SILVA, MD's most frequently prescribed drugs include Prednisone, Abiraterone Acetate, Anastrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CHAMATH DE SILVA, MD accept Medicare?
CHAMATH DE SILVA, MD appears in CMS Medicare data with 795 Part D claims and 160 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CHAMATH DE SILVA, MD's credentials?
CHAMATH DE SILVA, MD's NPI is 1568588184 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology